If you need more lookups,
subscriptions start at $34 USD/month.
Henry Skinner Location
Houston, TX, US
Henry Skinner Work
2021 -now Chief Executive Officer @
2017 -2021 Senior Vice President, Venture @
2008 -2017 Managing Director Novartis Venture Funds @
2006 -2008 Executive Director @
2006 -2008 Head Strategic Alliances, Therapeutics @
2005 -2007 Executive Director and Head Strategic Alliances, Therapeutics @
2005 -2006 Chief Executive Officer @
2004 -2006 Consultant @ CovX
Henry Skinner Education
Texas A&M University
(Health Care, Law)
2020-2021
Baylor College of Medicine
(Genetics)
1995-1997
University Of Illinois At Urbana - Champaign
Doctor of Philosophy (Microbiology)
1988-1995
Worcester Polytechnic Institute
Bachelor of Science (Biotechnology, Biology)
1982-1985
Portsmouth Abbey School
Henry Skinner Skills
Business Development
Management
Pharmaceutical Industry
Venture Capital
Regulatory Submissions
CRO
Medical Devices
Start-ups
FDA
Mergers & Acquisitions
Pharmaceutics
R&D
Lifesciences
Biotechnology
Strategic Alliances
Technology Transfer
Clinical Development
Drug Development
Oncology
Regulatory Affairs
Due Diligence
Drug Discovery
Biopharmaceuticals
Commercialization
Biochemistry
Clinical Trials
Vaccines
Cross-functional Team Leadership
GMP
Product Launch
GCP
Molecular Biology
Pharmaceutical Sales
Infectious Diseases
Validation
Licensing
Immunology
Market Access
Strategy
Corporate Development
Life Sciences
Cross Functional Team Leadership
Start Ups
Mergers and Acquisitions
Henry Skinner Summary
Henry Skinner, based in Houston, TX, US, is currently a Chief Executive Officer at AMR Action Fund. Henry Skinner brings experience from previous roles at Tekla Capital Management LLC and Novartis. Henry Skinner holds a 2020 - 2021 Texas A&M University. With a robust skill set that includes Business Development, Management, Pharmaceutical Industry, Venture Capital, Regulatory Submissions and more. Henry Skinner has 2 emails and 4 mobile phone numbers on RocketReach.
Looking for a different Henry Skinner?
Find contact details for 700 million professionals.